Related Experiment Videos
Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination
Shin Hisahara1, Hideyuki Okano, Masayuki Miura
1Department of Neurology, School of Medicine, Sapporo Medical University, South 1 West 17, Chuo-ku, Sapporo, Hokkaido 060-8556, Japan. hisahara@sapmed.ac.jp
Abstract:
Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are inflammatory diseases of the central nervous system (CNS) characterized by localized areas of demyelination. MS is believed to be an autoimmune disorder mediated by activated immune cells such as T- and B-lymphocytes and macrophages/microglia. Lymphocytes are primed in the peripheral tissues by antigens, and clonally expanded cells infiltrate the CNS. They produce large amounts of inflammatory and cytokines that lead to demyelination and axonal degeneration. Although several studies have shown that oligodendrocytes (OLGs), the myelin-forming glial cells in the CNS, are sensitive to cell death stimuli, such as cytotoxic cytokines, anti-myelin antibodies, nitric oxide, and oxidative stress, in vitro, the mechanisms underlying injury to the OLGs in MS/EAE remain unclear. Transgenic mice that express the anti-apoptotic protein specifically in OLGs and caspase-11-deficient mice are significantly resistant to EAE induction. Histopathological analyses show that the number of caspase-activated OLGs and dead OLGs are reduced in the CNS of these mice. The numbers of infiltrating immune cells and the amounts of cytokines are also markedly reduced in EAE lesions. Therefore, caspase-mediated OLG death leads to the exacerbation of demyelination and the deterioration of neurological manifestations by inducing local inflammatory events.
Insights
Caspase-mediated oligodendrocyte death exacerbates multiple sclerosis (MS) by worsening demyelination and neurological decline. Protecting oligodendrocytes (OLGs) may offer new therapeutic strategies for MS.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Pathology
Background:
- Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) are CNS inflammatory diseases causing demyelination.
- MS involves autoimmune-mediated attack on myelin by immune cells like T-lymphocytes and macrophages.
- Oligodendrocytes (OLGs), crucial for myelin formation, are vulnerable to various in vitro death stimuli, but in vivo mechanisms in MS remain unclear.
Purpose of the Study:
- To investigate the role of caspase-mediated oligodendrocyte death in the pathogenesis of MS/EAE.
- To determine if inhibiting oligodendrocyte apoptosis impacts EAE development and severity.
Main Methods:
- Utilized transgenic mice expressing anti-apoptotic proteins in OLGs and caspase-11-deficient mice.
- Induced experimental autoimmune encephalomyelitis (EAE) in these mouse models.
- Performed histopathological analyses of the central nervous system (CNS) to assess OLG death, immune cell infiltration, and cytokine levels.
Main Results:
- Transgenic and caspase-11-deficient mice showed significant resistance to EAE induction.
- Reduced numbers of caspase-activated and dead OLGs were observed in the CNS of these resistant mice.
- Markedly decreased immune cell infiltration and lower cytokine levels were found in EAE lesions.
Conclusions:
- Caspase-mediated oligodendrocyte death is a key factor driving demyelination and neurological deterioration in MS/EAE.
- Inhibiting oligodendrocyte apoptosis can reduce disease severity and inflammation.
- Targeting caspase pathways in OLGs presents a potential therapeutic avenue for multiple sclerosis.